Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jul;54(7):3043-6.
doi: 10.1128/AAC.00265-10. Epub 2010 Apr 26.

Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum beta-lactamases in community- and hospital-associated intra-abdominal infections in Europe: results of the 2008 Study for Monitoring Antimicrobial Resistance Trends (SMART)

Stephen P Hawser  1 , Samuel K Bouchillon, Daryl J Hoban, Robert E Badal, Rafael Cantón, Fernando Baquero
Affiliations

Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum beta-lactamases in community- and hospital-associated intra-abdominal infections in Europe: results of the 2008 Study for Monitoring Antimicrobial Resistance Trends (SMART)

Stephen P Hawser et al. Antimicrob Agents Chemother. 2010 Jul.

Abstract

From 2002 to 2008, there was a significant increase in extended-spectrum beta-lactamase (ESBL)-positive Escherichia coli isolates in European intra-abdominal infections, from 4.3% in 2002 to 11.8% in 2008 (P < 0.001), but not for ESBL-positive Klebsiella pneumoniae isolates (16.4% to 17.9% [P > 0.05]). Hospital-associated isolates were more common than community-associated isolates, at 14.0% versus 6.5%, respectively, for E. coli (P < 0.001) and 20.9% versus 5.3%, respectively, for K. pneumoniae (P < 0.01). Carbapenems were consistently the most active drugs tested.

PubMed Disclaimer

References

    1. Baquero, F., P. R. Hsueh, D. L. Paterson, F. Rossi, G. V. Bochicchio, G. Gallaghe, K. Lantz, J. B. Villasenor, K. McCarroll, M. A. Abramson, and J. W. Chow. 2009. In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2005 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). Surg. Infect. 10:99-104. - PubMed
    1. Ben-Ami, R., J. Rodriguez-Bano, H. Arsian, J. D. Pitout, C. Quentin, E. S. Calbo, O. K. Azap, C. Arpin, A. Pascual, D. M. Livermore, J. Garau, and Y. Carmeli. 2009. A multinational survey of risk factors for infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in nonhospitalized patients. Clin. Infect. Dis. 49:682-690. - PubMed
    1. Bochicchio, G. V., F. Baquero, P. R. Hsueh, D. L. Paterson, F. Rossi, T. A. Snyder, K. McCarroll, V. Satishchandran, M. J. Dinubile, and J. W. Chow. 2006. In vitro susceptibilities of Escherichia coli isolated from patients with intra-abdominal infections worldwide in 2002-2004: results from SMART (Study for Monitoring Antimicrobial Resistance Trends). Surg. Infect. 7:537-545. - PubMed
    1. Canton, R., A. Novais, A. Valverde, E. Machado, L. Peixe, F. Baquero, and T. M. Coque. 2008. Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe. Clin. Microbiol. Infect. 14(Suppl. 1):144-153. - PubMed
    1. Clinical and Laboratory Standards Institute. 2008. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A7, 7th ed. Clinical and Laboratory Standards Institute, Wayne, PA.

Publication types

MeSH terms

LinkOut - more resources